Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 12, 2022 (Week 10)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 49 400 2,194 1,407 1 13 55 28
New England - 17 42 64 - 1 - -
Connecticut - 6 12 20 - 0 - -
Maine - 7 13 10 - 0 - -
Massachusetts - 9 - 20 - 0 - -
New Hampshire - 4 8 7 - 1 - -
Rhode Island - 3 6 4 - 1 - -
Vermont - 3 3 3 - 0 - -
Middle Atlantic 21 82 366 220 1 6 14 11
New Jersey 1 12 38 51 1 3 3 11
New York (excluding New York City) 10 44 132 50 - 3 6 -
New York City 1 22 92 63 - 6 - -
Pennsylvania 9 18 104 56 - 2 5 -
East North Central 4 82 402 193 - 4 19 2
Illinois N NC N N N NC N N
Indiana - 25 53 55 - 1 1 -
Michigan - 18 67 46 - 2 3 1
Ohio - 41 213 89 - 4 15 1
Wisconsin 4 19 69 3 - 0 - -
West North Central 7 28 173 69 - 4 4 5
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 7 22 113 48 - 2 4 4
Nebraska - 7 29 7 - 0 - -
North Dakota - 3 8 3 - 0 - -
South Dakota - 7 23 11 - 3 - 1
South Atlantic 15 69 273 246 - 5 5 3
Delaware - 5 14 9 - 0 - -
District of Columbia - 2 4 3 - 0 - -
Florida 15 26 118 77 - 3 5 3
Georgia - 17 20 83 - 0 - -
Maryland - 11 - 39 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 25 96 - - 3 - -
Virginia - 1 - 1 - 0 - -
West Virginia - 13 21 34 - 0 - -
East South Central - 43 207 162 - 2 1 1
Alabama - 19 66 47 - 1 1 -
Kentucky - 8 30 15 - 2 - 1
Mississippi - 8 34 25 - 0 - -
Tennessee - 26 77 75 - 0 - -
West South Central - 63 141 137 - 3 1 4
Arkansas - 10 43 16 - 0 - -
Louisiana - 29 13 60 - 1 - -
Oklahoma N NC N N N NC N N
Texas - 53 85 61 - 3 1 4
Mountain 2 91 558 292 - 2 7 2
Arizona - 43 238 131 - 1 3 1
Colorado - 28 149 52 - 0 - -
Idaho N NC N N N NC N N
Montana - 5 12 10 - 1 - -
Nevada - 10 52 42 - 1 - -
New Mexico - 14 64 32 - 0 - -
Utah 2 12 43 20 - 1 4 1
Wyoming - 3 - 5 - 0 - -
Pacific - 12 32 24 - 2 4 -
Alaska - 11 30 20 - 2 4 -
California N NC N N N NC N N
Hawaii - 3 2 4 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 49 400 2,194 1,408 1 13 55 28
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.